首页> 外文期刊>human psychopharmacology: clinical and experimental >Cognitive functioning in a hypnotic drug trial
【24h】

Cognitive functioning in a hypnotic drug trial

机译:催眠药物试验中的认知功能

获取原文
获取外文期刊封面目录资料

摘要

AbstractIn a 2 week comparative trial between lormetazepam (LMA) and temazepam (TEM) in 162 insomniac patients, Critical Flicker Fusion Threshhold (CFFT) and Digit Symbol Substitution (DSS) tests were performed, pre‐treatment and at days 7 and 14. With neither drug was there any difference in CFFT, but highly significant improvement in DSS (p<0.001). Patients completed daily visual analogue scales concerned with various sleep parameters and daytime effects. Sleep was significantly improved with both drugs from day 1 onwards, as were daytime general wellbeing and alertness. There was significant improvement in daytime balance and coordination in the LMA group (p<0·001 by day 14) but not in the TEM group. Daytime anxiety improved significantly in both groups, but on day 14 this improvement was still significant in the LMA group (p<0·001) but not in the TEM group. The incidence of daytime fatigue (p<0·001), drowsiness (p<0·02) and headache (p<0·001) were significantlyreducedwith LMA and daytime fatigue (p<0·01) and headache (p<0·001) with TEM, but with no significant between group differences. Theseverityof daytime fatigue was significantly less with LMA than with TEM
机译:摘要在一项为期2周的氯美西泮(LMA)和替马西泮(TEM)对162例失眠患者进行的比较试验中,在治疗前以及第7天和第14天进行了临界闪烁融合脱粒(CFFT)和数字符号替换(DSS)测试。两种药物在CFFT方面没有任何差异,但在DSS方面有非常显着的改善(p<0.001)。患者完成了与各种睡眠参数和白天影响有关的每日视觉模拟量表。从第1天开始,两种药物的睡眠都得到了显着改善,白天的总体健康和警觉性也得到了改善。LMA组(p<0·001,第14天)的日间平衡和协调性有显著改善,但TEM组没有改善。两组的日间焦虑都有显著改善,但在第 14 天,这种改善在 LMA 组 (p<0·001) 中仍然显着,但在 TEM 组中没有。LMA组白天疲劳(p<0·001)、嗜睡(p<0·02)和头痛(p<0·001)的发生率显著降低,TEM组间疲劳(p<0·01)和头痛(p<0·001)的发生率显著降低,但组间差异无统计学意义。LMA组的日间疲劳明显低于TEM组

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号